Tag Archives: CRISPR
CASGEVY: Rethinking Drug Costs Through the Lens of Public Access
Maria Klimenko considers the extent to which the price of innovative treatments like CASGEVY, a type of gene therapy, should reflect not just the cost of development, but also their broader societal impact — and the public healthcare system’s ability to provide equitable access.
Human Genome Editing: From the First to the Third International Summit
Françoise Baylis discusses the outcome of the Third International Summit on Human Genome Editing.
Heritable Human Genome Editing? It May Never Be Safe
Katie Hasson recounts the recent failures to edit the human genome.
Prison sentence for creator of first CRISPR babies
Françoise Baylis calls for a critical analysis of the institutional context that contributed to the actions for which He Jiankui has been sentenced to prison.
The CRISPR Dream
Françoise Baylis shares a brief excerpt from her book Altered Inheritance: CRISPR and the Ethics of Human Genome Editing.
Impact Ethics 